Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $16.0000 (0.38%) ($15.4300 - $16.1700) on Thu. Aug. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.3% (three month average) | RSI | 82 | Latest Price | $16.0000(0.38%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | AUTL advances 4.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) IBB(17%) XBI(17%) ARKG(15%) SKYY(15%) LIT(14%) | Factors Impacting AUTL price | AUTL will decline at least -2.15% in a week (0% probabilities). VIXM(-9%) TBT(-7%) VXX(-4%) UNG(-4%) USO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.15% (StdDev 4.3%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $15.98(0.13%) | 10 Day Moving Average | $15.83(1.07%) | 20 Day Moving Average | $15.03(6.45%) | To recent high | -1.8% | To recent low | 41.2% | Market Cap | $836m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |